SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001068238-21-000038
Filing Date
2021-02-16
Accepted
2021-02-16 16:23:13
Documents
1
Group Members
DAVID COLLIERJAMES WATSONVELOCITY PHARMA MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 VELOCITY PHARMACEUTICAL HOLDINGS LLC SCHEDULE 13 G/A velocitypharma_sch-13ga.htm SC 13G/A 143188
  Complete submission text file 0001068238-21-000038.txt   145035
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80900 | Film No.: 21638956
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080 (650) 745-8179
VELOCITY PHARMACEUTICAL HOLDINGS LLC (Filed by) CIK: 0001802702 (see all company filings)

IRS No.: 452578473 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A